Skip to main content

Hereditary Amyloidosis clinical trials at UCSF
1 in progress, 0 open to new patients

  • ATTR Expanded Access Program (EAP) by Ionis

    Sorry, not accepting new patients

    The purpose of this program is to provide expanded access to Inotersen for up to 100 Patients with Hereditary Transthyretin Amyloidosis (hTTR).

    San Francisco, California and other locations